The circulating metabolome in idiopathic pulmonary fibrosis (IPF)
C. Hesslinger (Biberach , Germany), R. Overton (Durham, North Carolina, United States of America), S. Keller (Biberach , Germany), M. Neely (Durham, North Carolina, United States of America), J. Belperio (Los Angeles, California, United States of America), R. Vinisko (Ridgefield, Connecticut, United States of America), T. Leonard (Ridgefield, Connecticut, United States of America), K. Flaherty (Ann Arbor, Michigan, United States of America), I. Noth (Charlottesville, Virginia, United States of America), S. Palmer (Durham, North Carolina, United States of America), J. Todd (Durham, North Carolina, United States of America)
Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Hesslinger (Biberach , Germany), R. Overton (Durham, North Carolina, United States of America), S. Keller (Biberach , Germany), M. Neely (Durham, North Carolina, United States of America), J. Belperio (Los Angeles, California, United States of America), R. Vinisko (Ridgefield, Connecticut, United States of America), T. Leonard (Ridgefield, Connecticut, United States of America), K. Flaherty (Ann Arbor, Michigan, United States of America), I. Noth (Charlottesville, Virginia, United States of America), S. Palmer (Durham, North Carolina, United States of America), J. Todd (Durham, North Carolina, United States of America). The circulating metabolome in idiopathic pulmonary fibrosis (IPF). 1924
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: